Cutler Group LP Denali Therapeutics Inc. Put Options Transaction History

Cutler Group LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 01, 2023	SELL	$21.91 - $32.67 $63,539 - $94,743	-2,900 Reduced 72.5%	1,100 $2,000
Q3 2022 Oct 25, 2022	BUY	$25.97 - $38.53 $103,880 - $154,120	4,000 New	4,000 $21,000
Q1 2021 Apr 26, 2021	SELL	$53.8 - $81.53 $21,520 - $32,612	-400 Reduced 40.0%	600 $2,000
Q1 2020 May 07, 2020	BUY	$14.2 - $27.98 $14,200 - $27,980	1,000 New	1,000 $6,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.